OMALIZUMAB

UNII:	2P471X1Z11
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	OMALIZUMAB
GSRS Full Record:	2P471X1Z11 i

242138-07-4
CT-P39
CTP-39
CTP39
GBR 310
GBR-310
IGE25
Immunoglobulin G (human-mouse monoclonal E25 clone pSV1E26 -chain antihuman immunoglobulin E Fc region), disulfide with human-mouse monoclonal E25 clone pSVIE126 -chain, dimer
Immunoglobulin G, anti-(human immunoglobulin E Fc region) (human-mouse monoclonal E25 clone pSVIE26 -chain), disulfide with human-mouse monoclonal E25 clone pSVIE26 -chain, dimer
OMALIZUMAB (GENETICAL RECOMBINATION)
OMALIZUMAB BIOSIMILAR (CT-P39)
OMALIZUMAB BIOSIMILAR - GLENMARK PHARMACEUTICALS
OMALIZUMAB BIOSIMILAR - SYNERMORE
OMALIZUMAB [EMA EPAR]
OMALIZUMAB [JAN]
OMALIZUMAB [MART.]
OMALIZUMAB [MI]
OMALIZUMAB [PURPLE BOOK CDER]
OMALIZUMAB [USAN]
OMALIZUMAB [VANDF]
OMLYCLO
Omalizumab
Omalizumab [WHO-DD]
Omalizumab igec [WHO-DD]
Omalizumab-IGEC
RG-3648
RHUMAB-E25
SYN-008
SYN008
XOLAIR
omalizumab [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

OMALIZUMAB

Synonyms and Mappings

Resources